Abstract
Summary: In 2001 we identified a new inborn error of metabolism caused by a defect in the X-linked creatine transporter SLC6A8 gene mapped at Xq28 (SLC6A8 deficiency, McKusick 300352). An X-linked creatine transporter defect was presumed because of (1) the absence of creatine in the brain as indicated by proton magnetic resonance spectroscopy (MRS); (2) the elevated creatine levels in urine and normal guanidinoacetate levels in plasma, ruling out a creatine biosynthesis defect; (3) the absence of an improvement on creatine supplementation; and (4) the fact that the pedigree suggested an X-linked disease. Our hypothesis was proved by the presence of a hemizygous nonsense mutation in the male index patient and by the impaired creatine uptake by cultured fibroblasts. Currently, at least 7 unrelated families (13 male patients and 13 carriers) with a SLC6A8 deficiency have been identified. Four families come fromone metropolitan area. This suggests that SLC6A8 deficiency may have a relatively high incidence. The hallmarks of the disorder are X-linked mental retardation, expressive speech and language delay, epilepsy, developmental delay and autistic behaviour. In approximately 50% of the female carriers, learning disabilities of varying degrees have been noted.
Similar content being viewed by others
REFERENCES
Bizzi A, Bugiani M, Salomons GS, et al (2002) X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8. Ann Neurol 52: 227-231.
Cecil KM, Salomons GS, Ball WS, et al (2001) Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol 49: 401-404.
Cecil KM, DeGrauw TJ, Salomons GS, Jakobs C, Egelhoff JC, Clark JF (2003) Magnetic resonance spectroscopy in a 9-day-old heterozygous female child with creatine transporter deficiency. J Comput Assist Tomogr 27: 44-47.
deGrauw TJ, Salomons GS, Cecil KM, et al (2002) Congenital creatine transporter deficiency. Neuropediatrics 33: 232-238.
deGrauw TJ, Cecil KM, Byars AW, Ball WS, Jakobs C (2003) The clinical syndrome of creatine transporter deficiency. Mol Cell Biochem 244: 45-48.
Eichler EE, Lu F, Shen Y (1996) Duplication of a gene-rich cluster between 16pl 1.1 and Xq28: a novel pericentromeric-directed mechanism for paralogous genome evolution. Hum Mol Genet 5: 899-912.
Gregor P, Nash SR, Caron MG, Seldin MF, Warren ST (1995) Assignment of the creatine transporter gene (SLC6A8) to human chromosome Xq28 telomeric to G6PD. Genomics 25: 332-333.
Grunau C, Hindermann W, Rosenthal A (2000) Large-scale methylation analysis of human genomic DNA reveals tissue-specific differences between the methylation profiles of genes and pseudogenes. Hum Mol Genet 9: 2651-2663.
Hahn KA, Salomons GS, Tackels-Horne D (2002) X-linked mental retardation with seizure and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. Am J Hum Genet 70: 1349-1356.
Item CB, St6ckler-Ipsiroglu S, Stromberger C, et al (2001) Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet 69: 1127-1133.
Nash SR, Giros B, Kingsmore SF (1994) Cloning, pharmacological characterization, and genomic localization of the human creatine transporter. Receptors Channels 2: 165-174.
Salomons GS, Dooren JM, Verhoeven NM, et al (2001) X-linked creatine-transporter gene (SLC6A8) defect: a new creatine deficiency sydrome. Am J Hum Genet 68: 1497-1500.
Sandoval N, Bauer D, Brenner V (1996) The genomic organization of a human creatine trans-porter (CRTR) gene located in Xq28. Genomics 35: 383-385.
Schulze A, Hess T, Wevers R (1997) Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism. J Pediatr 131: 626-631.
Sora I, Richman J, Santoro G (1994) The cloning and expression of a human creatine trans-porter. Biochem Biophys Res Commun 204: 419-427.
St6ckler S, Isbrandt D, Hanefeld F, Schmidt B, von Figura K (1996a) Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. Am J Hum Genet 58: 914-922.
St6ckler S, Hanefeld F, Frahm J (1996b) Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 348: 789-790.
St6ckler S, Marescau B, De Deyn PP, Trijbels JM, Hanefeld F (1997) Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis. Metabolism 46: 1189-1193.
Stromberger C, Bodamer OA, St6ckler-Ipsiroglu S (2003) Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism. J Inherit Metab Dis 26: 299-308.
Struys EA, Jansen EE, ten Brink HJ, Verhoeven NM, van der Knaap MS, Jakobs C (1998) An accurate stable isotope dilution gas chromatographic mass spectrometric approach to the diagnosis of guanidinoacetate methyltransferase deficiency. J Pharm Biomed Anal 18: 659-665.
Tarnopolsky MA, Beal MF (2001) Potential for creatine and other therapies targetting cellular energy dysfunction in neurological disorders. Ann Neurol 49: 561-574.
van der Knaap MS, Verhoeven NM, Maaswinkel-Mooij P, et al (2000) Mental retardation and behavioral problems as presenting signs of creatine synthesis defect. Ann Neurol 47: 540-543.
Walker JB (1979) Creatine: biosynthesis, regulation and function. Adv Enzymol Relat Areas Mol Biol 50: 177-242.
Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80: 1107-1213.
Wyss M, Schulze A (2002) Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience 112: 243-260.
Xu W, Liu L, Gorman PA, Sheer D, Emson PC (1997) Assignment of the human creatine transporter type 2 (SLC6A10) to chromosome band 16p11.2 by in situ hybridization. Cytogenet Cell Genet 76: 19.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salomons, G.S., Van Dooren, S.J.M., Verhoeven, N.M. et al. X-linked creatine transporter defect: An overview. J Inherit Metab Dis 26, 309–318 (2003). https://doi.org/10.1023/A:1024405821638
Issue Date:
DOI: https://doi.org/10.1023/A:1024405821638